RE: What N4p are trying to do with Nuvec and its strategy16 Aug 2020 14:28
From 06/07 rns it looks like the investigations into the oral applications are currently at the in-vitro phase Maz:
'To that end the Company will working with Evotec to undertake some preliminary in vitro studies to establish first that Nuvec® can be optimised to transfect murine intestinal cells and, secondly, that it can transfect human gastrointestinal mucosal/epithelial cells. Without being able to efficiently transfect gut cells, any oral application would not be possible, so it is essential to complete these studies prior to progressing any further with this initiative.'
Assuming this study was started immediately, we could be approx 45 days into these works so news could come at any time on this.
Also awaiting further updates on:
viral vector manufacturing
the pre in-vivo study
Dispersion / agglomeration works
Ongoing potential commercial partner discussions
All the above have the potential to be transformational....Great time to be in here. I'm sure i've missed items out so please add them on.